Document is current

Any future updates will be listed below

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Crossref DOI link: https://doi.org/10.1007/s00262-024-03873-5

Published Online: 2024-12-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark